GL1X · GenesisL1 explorer

MolNFT v1 · #181164 · protein

Structure of full-length human lambda-6A light chain jto in complex with stabilizer 34 [3-(2-(7-(diethylamino)-4-methyl-2-oxo-2H-chromen- 3-YL)ETHYL)-7-(1H-imidazole-5-carbonyl)-1,3,7-TRIAZASPIRO[4.4]NONANE- 2,4-dione]

7LMO · Jto light chain: “Structure of full-length human lambda-6A light chain jto in complex with stabilizer 34…”. X-ray diffraction, 2 ligands (NYO, PO4), 6 pockets (best druggability 0.63). MolNFT v1 #181164 on GenesisL1: 3D structure…

PDB
7LMO
Type
protein
Length
430 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Jto light chain
Ligands
NYO, PO4
Pockets
6 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BJto light chainprotein2157% helix, 48% strand—

Ligands and binding sites

  • NYO · (5~{R})-3-[2-[7-(diethylamino)-4-methyl-2-oxidanylidene-chromen-3-yl]ethyl]-7-(1~{H}-imidazol-4-ylcarbonyl)-1,3,7-triazaspiro[4.4]nonane-2,4-dione · ligand · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15770.630.7554empty
2840.590.8714NYO
33250.570.7656empty
42250.530.7629NYO
5860.350.7520empty

Interfaces

1 interface between chains.

  • A–B · 1729 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 7LMO · Structure of full-length human lambda-6A light chain JTO in complex with stabilizer 34… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.